He is an investigator in National Institutes of Health (NIH)-sponsored research networks and is conducting studies to identify new treatment strategies for patients with asthma and COPD. Dr. Krishnan served as a member of the Pulmonary-Allergy Drugs Advisory Committee for the U.S. Food and Drug Administration (FDA) from 2007-2012 (Chair, 2011-2012). He is a member of the National Committee for Quality Assurance (NCQA) Respiratory Measurement Advisory Panel (2010- present) and the National Heart, Lung, and Blood Institute's Clinical Trials Review Committee (2012- present). Gender : Male